Bartosz Wasag, Els Lierman, Peter Meeus, Jan Cools, Peter Vandenberghe. The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11). haematol [Internet]. 2011Jun.1 [cited 2024Apr.27];96(6):922-6. Available from: https://haematologica.org/article/view/6001